MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION

Rhea-AI Summary

Marpai (OTCQX: MRAI) announced renewal of its access to the Aetna Signature Administrator (ASA) PPO network and integration of the Aetna Faircost Optimizer, while reporting a better-than-expected 2026 sales cycle with new clients effective January 1, 2026. The ASA renewal preserves broad national provider access and competitive network discounts for Marpai's self-funded employer clients, maintaining continuity of care. The Faircost Optimizer adds an integrated tool to manage out-of-network claims and limit balance-billing exposure. Management describes the combination of enhanced network access and cost-containment tools as reinforcing Marpai's path to scalable growth and previously guided profitability targets for 2026.

Positive

• Renewed Aetna Signature Administrator PPO network access
• Integrated Aetna Faircost Optimizer for out-of-network cost control
• Robust sales cycle with new clients effective Jan 1, 2026

Negative

• None.

News Market Reaction

-8.59%

1 alert

-8.59% News Effect

On the day this news was published, MRAI declined 8.59%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

New client start date: January 1, 2026 Sales year focus: 2026

2 metrics

New client start date January 1, 2026 Effective date for newly secured clients referenced in sales cycle

Sales year focus 2026 Better-than-expected sales cycle for 2026

Market Reality Check

Price: $0.7883 Vol: Volume 8,807 is at 32% of...

low vol

$0.7883 Last Close

Volume Volume 8,807 is at 32% of the 20-day average (27,928) ahead of this news. low

Technical Shares at $0.8001 were trading below the 200-day MA of $1.20 before the announcement.

Peers on Argus

Peers showed mixed but mostly positive moves, with PFHO up 3.96%, CSDX up 4.43%,...

Peers showed mixed but mostly positive moves, with PFHO up 3.96%, CSDX up 4.43%, VASO up 0.52%, while OTLC fell 2.36%. No evidence of a coordinated sector move tied to this headline.

Historical Context

5 past events · Latest: Dec 01 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 01	Network partnership	Positive	-8.6%	Renewal of Aetna ASA PPO access and addition of Faircost Optimizer tool.
Nov 12	Earnings update	Positive	-1.0%	Q3 2025 cost cuts, narrower losses, $3.9M PIPE, profitability target Q1 2026.
Nov 06	Earnings call notice	Neutral	-4.4%	Announcement of Nov 13 webcast to discuss Q3 2025 results.
Oct 14	Industry recognition	Positive	-2.7%	Named a Top Health Plan Third Party Administrator for 2025.
Oct 06	Insider investment	Positive	-4.3%	CEO-linked fund invested about $200,000 via private placement in Q3 2025.

Pattern Detected

Recent history shows a pattern of negative price reactions following generally positive or neutral news, including partnership, earnings, awards, and insider investment announcements.

Recent Company History

This announcement builds on several 2025 developments. In Q3 2025, Marpai reported a 24% reduction in operating expenses, narrower operating and net losses, and closed a $3.9 million PIPE while targeting profitability in Q1 2026. The company was recognized as a Top Health Plan TPA and raised roughly $1.7 million in Q3 private placements, including an additional $200,000 from the CEO’s fund. Despite these seemingly constructive updates, shares posted negative 24-hour reactions after each of these prior news events.

Market Pulse Summary

The stock moved -8.6% in the session following this news. A negative reaction despite positive opera...

Analysis

The stock moved -8.6% in the session following this news. A negative reaction despite positive operational news fits the recent pattern, where prior announcements—including cost reductions, insider investments, and industry recognition—were followed by 24-hour declines of up to 8.59%. While the Aetna ASA PPO renewal and Faircost Optimizer integration strengthen Marpai’s offering, recent filings highlighted revenue contraction, high liabilities, and going-concern language, which could have outweighed the partnership narrative in market perception.

Key Terms

pharmacy benefit management, third-party administration, ppo network, out-of-network claims, +1 more

5 terms

pharmacy benefit management medical

"a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM)"

Pharmacy benefit management is a business that acts like a shopping agent for prescription drugs: it negotiates prices with drug makers, decides which medicines are covered, processes claims, and runs or networks pharmacies on behalf of insurers, employers, and government plans. Investors care because these managers influence drug costs, company revenues and profit margins, and are sensitive to changes in regulations or shifts in how drugs are bought and paid for.

third-party administration technical

"Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services"

Third-party administration is when an outside firm handles administrative tasks for benefit plans, insurance policies, or other corporate programs—things like processing claims, keeping records, and managing payments. Investors care because using a specialist can lower a company’s operating burden and costs, affect reported liabilities and cash flow, and introduce operational or compliance risk if the administrator makes errors; think of it like hiring a property manager to run an apartment complex instead of the owner doing every task.

ppo network technical

"access the Aetna Signature Administrator (ASA) PPO network"

A PPO network is a group of doctors, hospitals and other health providers that contract with an insurer to offer care at agreed-upon rates while still letting patients see providers outside the network for higher costs. For investors, the size, pricing and rules of a PPO network influence how often care is used, how much insurers and providers can earn, and how predictable margins are—think of it like a preferred shopping club that steers customers and sets discount levels.

out-of-network claims technical

"manage their out-of-network claims costs, which are often unpredictable"

Out-of-network claims are medical bills submitted for care provided by a doctor or facility that does not have a contract with the patient’s insurer; the insurer may pay less or deny the claim and the patient can be billed for the balance. For investors, these claims affect healthcare company revenues, insurer payouts, and patient demand because disputes over payment levels can change cash flow, increase reserve needs, and prompt regulatory or legal challenges — like an unexpected bill after a service from a non-contracted vendor.

balance billing financial

"protecting self-funded plans from excessive balance billing"

Balance billing is when a medical provider bills a patient for the difference between what the provider charges and what the patient’s insurer pays. Think of it like being given a restaurant bill after your card payment because the restaurant and the card company didn’t agree on the price; for investors, it matters because changes in rules, dispute rates, or provider reliance on balance billing can affect patient out-of-pocket risk, provider revenue stability, and regulatory or reputational exposure.

AI-generated analysis. Not financial advice.

Renews Aetna Signature Administrator Network Agreement and Enhances Cost Containment with Faircost Optimizer

TAMPA, Fla., Dec. 1, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced significant positive momentum heading into the new year, highlighted by a better-than-expected sales cycle for 2026 and the renewal of its critical network access agreement with Aetna.

The Company reports a robust sales cycle, securing a volume of new clients for January 1, 2026, that surpasses internal expectations, reinforcing its path to scalable growth and previously guided profitability targets.

In a move that solidifies its premier network offering, Marpai has successfully renewed its agreement to access the Aetna Signature Administrator (ASA) PPO network. This renewal ensures that Marpai's self-funded employer clients and their members continue to receive broad, national access to Aetna's extensive network of high-quality providers, maintaining continuity of care and competitive network discounts.

Furthermore, Marpai will now offer the Aetna Faircost Optimizer as an integrated cost management tool for benefit plan administrators. The Faircost Optimizer is designed to help plan sponsors effectively manage their out-of-network claims costs, which are often unpredictable and challenging to control. By leveraging this sophisticated tool, Marpai enhances its ability to deliver superior cost containment, providing maximum savings on non-contracted claims and protecting self-funded plans from excessive balance billing.

Damien Lamendola, Chief Executive Officer of Marpai, stated, "Our strategy of combining innovative technology with best-in-class network access is clearly resonating in the market. The success of our 2026 sales cycle, coupled with the important renewal of the Aetna Signature Administrator network agreement, sets a strong foundation for the year ahead. The addition of Aetna's Faircost Optimizer transforms our offering, handing clients a powerful lever to slash out-of-network liabilities and drive significant plan savings."

About Marpai, Inc.

Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA, PBM and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $150 billion TPA sector serving self-funded employer health plans representing over $1.5 trillion in annual claims. Through its Marpai Saves initiative, the Company works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://ir.marpaihealth.com.

Forward-Looking Statement Disclaimer

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward-looking statements when it discusses the current sales rate for Q1 2026 and the impact of the Aetna Signature Network and Faircost Optimizer program. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-announces-2026-momentum-and-key-partnership-expansion-302629508.html

SOURCE Marpai

FAQ

What did Marpai (MRAI) announce on December 1, 2025 about Aetna network access?

Marpai renewed access to the Aetna Signature Administrator (ASA) PPO network, preserving national provider coverage for its self-funded clients.

How will the Aetna Faircost Optimizer affect Marpai (MRAI) clients in 2026?

The Faircost Optimizer will be offered as an integrated tool to help manage out-of-network claims and reduce balance-billing exposure.

What timing did Marpai (MRAI) give for new client starts from its 2026 sales cycle?

Marpai said it secured a volume of new clients scheduled to begin on January 1, 2026.

Does the December 1, 2025 announcement change Marpai's profitability outlook for 2026?

Marpai stated the sales momentum and network renewal reinforce its path to previously guided profitability targets for 2026.

Will Marpai's self-funded employer clients keep current provider access after the renewal?

Yes; the ASA renewal maintains broad, national access to Aetna's provider network for Marpai clients.